HIV / AIDS in the News

Celebrating their status - Mirror Indy

 

Wilmington nonprofit receives grant to boost HIV awareness in the Cape Fear - WECT

 

Programs work to prevent the spread of HIV to babies in Baton Rouge - WAFB

 

Programs work to prevent the spread of HIV to babies in Baton Rouge - WAFB

 

After Complaints, Health Insurer Agrees to Cover Common HIV Meds - POZ

 

NIH Announces Awards to Advance Tech for HIV Viral Load Detection - POZ

 

What Is PrEP and How Does It Prevent HIV? - Health Matters

 

Lusophone countries united to eliminate HIV, hepatitis, STIs and TB by 2030 - World Health Organization

 

Lily Phillips reveals she had to bed 100 men to go ‘viral’ and says HIV would be a ‘consequence of her acti... - The Sun

 

White House Symposium Focuses on Quality of Life Among People With HIV (Video) - HIV.gov

 

HopeHealth Hosted Annual Aidswalk - Manning Live

 

Researchers Investigate Potential Treatment for Eliminating HIV from the Brain - National Institute of Mental Health

 

First Severe Case of Bird Flu Detected in Louisiana - Drug Topics

 

Merck’s doravirine/islatravir combo yields positive results in Phase 3 HIV-1 trials - World Pharmaceutical Frontiers

 

Building country-led sustainable HIV responses - UNAIDS

 

Merck & Co buoyed by Phase III results with HIV tablet - The Pharma Letter

 

MSD’s DOR/ISL regimen meets primary efficacy hypotheses in HIV-1 treatment trials - Yahoo Finance

 

RIDOH effort aims to lower the barriers to getting HIV meds - Providence Business News

 

Driving change through sports and HIV awareness - UNAIDS

 

Two million people to benefit from injectable HIV drug - Nation

 

Merck & Co. makes an HIV comeback after safety concerns grounded testing - FirstWord Pharma

 

NIH Announces Awards to Advance Tech for HIV Viral | Newswise - Newswise

 

Gilead plans to halt free access to an HIV drug, worrying patient advocates - STAT

 

Positive Destinations: HIV Justice Network Rebrands HIV-Specific Travel Guide - POZ

 

Opinion: The world has a new HIV prevention drug. Let’s use it - Devex

 

Gilead’s twice-yearly PrEP chosen as breakthrough of the year - Bay Area Reporter, America's highest circulation LGBT newspaper

 

Merck's Investigational Two-Drug Regime For HIV Meets Primary Goal In Two Late-Stage Trials - Benzinga

 

Merck's Investigational Two-Drug Regime For HIV Meets Primary Goal In Two Late-Stage Trials - Yahoo Finance

 

Addressing Clinician-Reported Barriers Improves Confidence in PrEP Prescribing - Physician's Weekly

 

UNL professor granted millions for HIV vaccine research - KEYT